• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

多溴二苯醚:针对丙型肝炎病毒NS3解旋酶抑制作用的构效关系研究

PBDE: structure-activity studies for the inhibition of hepatitis C virus NS3 helicase.

作者信息

Salam Kazi Abdus, Furuta Atsushi, Noda Naohiro, Tsuneda Satoshi, Sekiguchi Yuji, Yamashita Atsuya, Moriishi Kohji, Nakakoshi Masamichi, Tani Hidenori, Roy Sona Rani, Tanaka Junichi, Tsubuki Masayoshi, Akimitsu Nobuyoshi

机构信息

Radioisotope Center, The University of Tokyo, 2-11-16 Yayoi, Bunkyo-ku, Tokyo 113-0032, Japan.

Department of Life Science and Medical Bioscience, Waseda University, 2-2 Wakamatsu-cho, Shinjuku-ku, Tokyo 162-8480, Japan.

出版信息

Molecules. 2014 Apr 2;19(4):4006-20. doi: 10.3390/molecules19044006.

DOI:10.3390/molecules19044006
PMID:24699145
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6271602/
Abstract

The helicase portion of the hepatitis C virus nonstructural protein 3 (NS3) is considered one of the most validated targets for developing direct acting antiviral agents. We isolated polybrominated diphenyl ether (PBDE) 1 from a marine sponge as an NS3 helicase inhibitor. In this study, we evaluated the inhibitory effects of PBDE (1) on the essential activities of NS3 protein such as RNA helicase, ATPase, and RNA binding activities. The structure-activity relationship analysis of PBDE (1) against the HCV ATPase revealed that the biphenyl ring, bromine, and phenolic hydroxyl group on the benzene backbone might be a basic scaffold for the inhibitory potency.

摘要

丙型肝炎病毒非结构蛋白3(NS3)的解旋酶部分被认为是开发直接作用抗病毒药物最有效的靶点之一。我们从一种海洋海绵中分离出多溴二苯醚(PBDE)1作为NS3解旋酶抑制剂。在本研究中,我们评估了PBDE(1)对NS3蛋白基本活性的抑制作用,如RNA解旋酶、ATP酶和RNA结合活性。PBDE(1)对HCV ATP酶的构效关系分析表明,苯骨架上的联苯环、溴和酚羟基可能是抑制效力的基本支架。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e2d3/6271602/dbd101f5bec5/molecules-19-04006-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e2d3/6271602/2748331280c9/molecules-19-04006-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e2d3/6271602/28eda0fd5290/molecules-19-04006-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e2d3/6271602/224425b92445/molecules-19-04006-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e2d3/6271602/9bbec60fba47/molecules-19-04006-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e2d3/6271602/707b68c2a823/molecules-19-04006-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e2d3/6271602/e621e315f8a2/molecules-19-04006-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e2d3/6271602/dbd101f5bec5/molecules-19-04006-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e2d3/6271602/2748331280c9/molecules-19-04006-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e2d3/6271602/28eda0fd5290/molecules-19-04006-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e2d3/6271602/224425b92445/molecules-19-04006-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e2d3/6271602/9bbec60fba47/molecules-19-04006-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e2d3/6271602/707b68c2a823/molecules-19-04006-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e2d3/6271602/e621e315f8a2/molecules-19-04006-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e2d3/6271602/dbd101f5bec5/molecules-19-04006-g007.jpg

相似文献

1
PBDE: structure-activity studies for the inhibition of hepatitis C virus NS3 helicase.多溴二苯醚:针对丙型肝炎病毒NS3解旋酶抑制作用的构效关系研究
Molecules. 2014 Apr 2;19(4):4006-20. doi: 10.3390/molecules19044006.
2
Cholesterol sulfate as a potential inhibitor of hepatitis C virus NS3 helicase.胆固醇硫酸酯作为丙型肝炎病毒 NS3 解旋酶的潜在抑制剂。
J Enzyme Inhib Med Chem. 2014 Apr;29(2):223-9. doi: 10.3109/14756366.2013.766607. Epub 2013 Feb 25.
3
Psammaplin A inhibits hepatitis C virus NS3 helicase.沙巴林 A 抑制丙型肝炎病毒 NS3 解旋酶。
J Nat Med. 2013 Oct;67(4):765-72. doi: 10.1007/s11418-013-0742-7. Epub 2013 Jan 29.
4
In vitro selection of RNA aptamers against the HCV NS3 helicase domain.针对丙型肝炎病毒NS3解旋酶结构域的RNA适体的体外筛选。
Oligonucleotides. 2004;14(2):114-29. doi: 10.1089/1545457041526335.
5
Real-time monitoring of RNA helicase activity using fluorescence resonance energy transfer in vitro.利用体外荧光共振能量转移实时监测 RNA 解旋酶活性。
Biochem Biophys Res Commun. 2010 Feb 26;393(1):131-6. doi: 10.1016/j.bbrc.2010.01.100. Epub 2010 Feb 1.
6
Identification of Hydroxyanthraquinones as Novel Inhibitors of Hepatitis C Virus NS3 Helicase.鉴定羟基蒽醌为丙型肝炎病毒NS3解旋酶的新型抑制剂
Int J Mol Sci. 2015 Aug 7;16(8):18439-53. doi: 10.3390/ijms160818439.
7
NS3 Peptide, a novel potent hepatitis C virus NS3 helicase inhibitor: its mechanism of action and antiviral activity in the replicon system.NS3肽,一种新型强效丙型肝炎病毒NS3解旋酶抑制剂:其在复制子系统中的作用机制和抗病毒活性
Antimicrob Agents Chemother. 2008 Feb;52(2):393-401. doi: 10.1128/AAC.00961-07. Epub 2007 Nov 26.
8
Designing and analysis of a potent bi-functional aptamers that inhibit protease and helicase activities of HCV NS3.抑制丙型肝炎病毒NS3蛋白酶和螺旋酶活性的高效双功能适体的设计与分析
Nucleic Acids Symp Ser (Oxf). 2004(48):195-6. doi: 10.1093/nass/48.1.195.
9
Probing the relationship between RNA-stimulated ATPase and helicase activities of HCV NS3 using 2'-O-methyl RNA substrates.使用2'-O-甲基RNA底物探究丙型肝炎病毒NS3的RNA刺激的ATP酶活性与解旋酶活性之间的关系。
Biochemistry. 2000 Mar 14;39(10):2619-25. doi: 10.1021/bi992127a.
10
Structure and function of hepatitis C virus NS3 helicase.丙型肝炎病毒NS3解旋酶的结构与功能
Curr Top Microbiol Immunol. 2000;242:171-96. doi: 10.1007/978-3-642-59605-6_9.

引用本文的文献

1
BDE-47 Induces Immunotoxicity in RAW264.7 Macrophages through the Reactive Oxygen Species-Mediated Mitochondrial Apoptotic Pathway.BDE-47 通过活性氧介导的线粒体凋亡途径诱导 RAW264.7 巨噬细胞免疫毒性。
Molecules. 2023 Feb 21;28(5):2036. doi: 10.3390/molecules28052036.
2
Ecological and Pharmacological Activities of Polybrominated Diphenyl Ethers (PBDEs) from the Indonesian Marine Sponge .印尼海洋海绵中多溴联苯醚(PBDEs)的生态和药理学活性。
Mar Drugs. 2021 Oct 27;19(11):611. doi: 10.3390/md19110611.
3
40 Years of Research on Polybrominated Diphenyl Ethers (PBDEs)-A Historical Overview and Newest Data of a Promising Anticancer Drug.

本文引用的文献

1
Inhibition of hepatitis C virus NS3 helicase by manoalide.马尼酸抑制丙型肝炎病毒 NS3 解旋酶。
J Nat Prod. 2012 Apr 27;75(4):650-4. doi: 10.1021/np200883s. Epub 2012 Mar 6.
2
New insights into HCV replication: potential antiviral targets.丙型肝炎病毒复制的新见解:潜在的抗病毒靶点。
Top Antivir Med. 2011 Aug-Sep;19(3):117-20.
3
An update on treatment of genotype 1 chronic hepatitis C virus infection: 2011 practice guideline by the American Association for the Study of Liver Diseases.1型慢性丙型肝炎病毒感染治疗的最新进展:美国肝病研究协会2011年实践指南
四十年多溴联苯醚(PBDEs)研究——一种有前途的抗癌药物的历史概述和最新数据。
Molecules. 2021 Feb 13;26(4):995. doi: 10.3390/molecules26040995.
4
Marine spongean polybrominated diphenyl ethers, selective growth inhibitors against the cancer cells adapted to glucose starvation, inhibits mitochondrial complex II.海洋海绵多溴二苯醚是适应葡萄糖饥饿的癌细胞的选择性生长抑制剂,可抑制线粒体复合物II。
J Nat Med. 2017 Jan;71(1):44-49. doi: 10.1007/s11418-016-1025-x. Epub 2016 Jul 23.
5
Identification of Antiviral Agents Targeting Hepatitis B Virus Promoter from Extracts of Indonesian Marine Organisms by a Novel Cell-Based Screening Assay.通过一种新型细胞筛选检测方法从印度尼西亚海洋生物提取物中鉴定靶向乙型肝炎病毒启动子的抗病毒药物
Mar Drugs. 2015 Nov 6;13(11):6759-73. doi: 10.3390/md13116759.
6
Unzippers, resolvers and sensors: a structural and functional biochemistry tale of RNA helicases.解旋酶、分解酶与传感器:RNA解旋酶的结构与功能生物化学故事
Int J Mol Sci. 2015 Jan 22;16(2):2269-93. doi: 10.3390/ijms16022269.
Hepatology. 2011 Oct;54(4):1433-44. doi: 10.1002/hep.24641. Epub 2011 Sep 26.
4
Telaprevir for retreatment of HCV infection.特拉匹韦治疗丙型肝炎病毒感染。
N Engl J Med. 2011 Jun 23;364(25):2417-28. doi: 10.1056/NEJMoa1013086.
5
Telaprevir for previously untreated chronic hepatitis C virus infection.替拉瑞韦治疗初治慢性丙型肝炎病毒感染。
N Engl J Med. 2011 Jun 23;364(25):2405-16. doi: 10.1056/NEJMoa1012912.
6
Introduction: a smouldering public-health crisis.引言:一场隐匿的公共卫生危机。
Nature. 2011 Jun 8;474(7350):S2-4. doi: 10.1038/474S2a.
7
Boceprevir for previously treated chronic HCV genotype 1 infection.博赛泼维用于治疗既往慢性 HCV 基因 1 型感染。
N Engl J Med. 2011 Mar 31;364(13):1207-17. doi: 10.1056/NEJMoa1009482.
8
Boceprevir for untreated chronic HCV genotype 1 infection.博赛泼维用于治疗未经治疗的慢性 HCV 基因 1 型感染。
N Engl J Med. 2011 Mar 31;364(13):1195-206. doi: 10.1056/NEJMoa1010494.
9
Development of novel antiviral therapies for hepatitis C virus.新型丙型肝炎抗病毒疗法的研发。
Virol Sin. 2010 Aug;25(4):246-66. doi: 10.1007/s12250-010-3140-2. Epub 2010 Jul 28.
10
Hepatitis C virus non-structural protein 3 (HCV NS3): a multifunctional antiviral target.丙型肝炎病毒非结构蛋白 3(HCV NS3):一种多功能抗病毒靶标。
J Biol Chem. 2010 Jul 23;285(30):22725-31. doi: 10.1074/jbc.R110.125294. Epub 2010 May 10.